Clinical Trials Directory

Trials / Unknown

UnknownNCT04310618

Mucus Solids Concentration in Patients With Bronchiectasis

Characterization of Mucus Solids Concentration in Patients With Bronchiectasis: Cross-sectional Study

Status
Unknown
Phase
Study type
Observational
Enrollment
36 (estimated)
Sponsor
Universidad San Jorge · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is a need for biomarkers that can rapidly and sensitively detect therapeutic benefits of therapies designed to "rehydrate" airways and monitor disease severity and progression. In this study the investigators will evaluate the stability of mucus concentration in patients with bronquiectasis (CF and NCBF) and its ability to respond to acute exacerbations in order to assess whether it can be a good candidate for biomarker.

Detailed description

Prospective cross-sectional study of repeated measurements. The recruitment will be performed in 3 different cities of Spain: Zaragoza, Barcelona and Murcia. Subjects will be asked to repeatedly collect spontaneous and induced sputum samples in both stable and exacerbated conditions. All samples will be collected autonomously by patients in their homes after they have been instructed and supervised. Hypertonic saline nebulization will be used for sputum induction.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2020-12-21
Primary completion
2023-03-01
Completion
2023-08-01
First posted
2020-03-17
Last updated
2021-10-01

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04310618. Inclusion in this directory is not an endorsement.